Martin Gore - Concepedia

Author

Martin Gore

Also Known As

Alice S Whittemore, Amanda Toland, Andrew K Godwin, Andrew Wotherspoon, Anna Marie Mulligan, Brooke L Fridley, Brown, Robert, Campbell, Ian, D Marshall, E Gilbey

692

Publications

60.5K

Citations

109

H-Index

143

Concepts

All Affiliations

Royal Marsden Hospital Royal Marsden NHS Foundation Trust Institute of Cancer Research Cancer Research UK University College London

About

Martin Gore is an author at Royal Marsden Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	51	129	17.8K
2	Health Sciences	15	19	854
3	Public Health	4	4	338
4	Natural Sciences	3	3	83
5	Business	1	1	10

Martin Gore

258

Publications

52.1K

Citations

H-Index

Page 1

	Year	Citations
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing Marco Gerlinger, Andrew J. Rowan, Stuart Horswell, New England Journal of Medicine	2012	7.6K
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma Bernard Escudier, Tim Eisen, Walter M. Stadler, New England Journal of Medicine	2007	4.8K
Carboplatin dosage: prospective evaluation of a simple formula based on renal function. A. Hilary Calvert, David R. Newell, Lindsey Gumbrell, Journal of Clinical Oncology PharmacotherapyPhysiologically-based Pharmacokinetic ModelingPharmacokineticsCarboplatin DosageRenal Function	1989	1.9K
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial Brian I. Rini, Bernard Escudier, Piotr Tomczak, The Lancet Comparative EffectivenessUrologyOncologyAxitinib Versus SorafenibGenitourinary Cancer	2011	1.8K
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma Mark R. Middleton, Jean‐Jacques Grob, Neil K. Aaronson, Journal of Clinical Oncology	2000	1.3K
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing Marco Gerlinger, Stuart Horswell, James Larkin, Nature Genetics UrologyGenitourinary CancerTumor HeterogeneitySingle Cell SequencingPathology	2014	1.2K
Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan Alan N. Gordon, John Fleagle, David Guthrie, Journal of Clinical Oncology	2001	1.2K
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma David F. McDermott, Mahrukh Huseni, Michael B. Atkins, Nature Medicine UrologyGenitourinary CancerMedicinePathologyBevacizumab Versus Sunitinib	2018	1.2K
A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer Fadlo R. Khuri, John Nemunaitis, Ian Ganly, Nature Medicine Intratumoral Onyx-015Neck CancerMedicinePathologyHead And Neck Cancer	2000	1.1K
Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial Bernard Escudier, Tim Eisen, Walter M. Stadler, Journal of Clinical Oncology	2009	1.1K

Page 1